Health plans are projecting the highest medical cost trend in nearly two decades, with the commercial health care cost trend expected to rise to 9% in 2027, the highest in 17 years. This increase reflects the convergence of several powerful forces reshaping the health care landscape, according to a PWC report.
"The challenge now is not simply understanding what is driving health care costs higher," the report said. "But whether health plans can deploy cost-of-care strategies quickly and effectively enough to slow the trajectory before affordability, coverage and access come under greater strain across the health care system."
The report cites five factors that are contributing to this trend:
- AI-enabled tools help providers capture more revenue;
- Inflation and provider consolidation drive up reimbursement rates
- Pharmacy costs continue to increase;
- Behavioral health utilization keeps growing; and
- The No Surprises Act arbitration process adds a new source of out-of-network reimbursement.
Together, these dynamics signal the urgency to find counterbalances to medical cost inflators in a health care system under constant affordability pressure. PWC recommends that health plans prioritize five cost-of-care actions.
Start with payment integrity. As AI-enabled documentation and coding tools become more widespread, health plans are seeing higher paid amounts per claim and greater variation in coding intensity. Payers should respond by assessing high-dollar claims before payment is made, tracking provider-level severity drift and integrating contract terms, payment policy and claims edits into a single accuracy engine. The goal should be more inaccurate payments, not more denials of claims.
Manage utilization in a more targeted and not simply restrictive way. Retire low-yield prior authorization requirements, reward high-performing providers and concentrate clinical review on the services where cost and variation are highest.
Focus on critical pharmacy management. GLP-1s, specialty drugs and medical-benefit therapies are contributing to pharmacy trend. Plans need class-specific governance, disciplined GLP-1 access policies by indication, accelerated biosimilar conversion for real savings and tighter alignment among pharmacy, utilization management and site-of-care programs.
Use network and reimbursement strategy. Plans should use price transparency along with their own claims experience to identify high-cost outliers, reset value-based contracts around specific cost drivers and direct members to lower-cost sites of care.
Make care management more disciplined and event-driven. Plans should set explicit trend-deflation targets by lever, hold vendors to outcomes that matter and stop funding programs that cannot demonstrate avoided utilization or measurable savings.
"All health care leaders should read the 2027 medical cost trend as a watershed moment to reflect on what will happen in the next few years as employers will likely not be able to sustain the same benefits and will likely mimic the actions of government health plans," the report concluded. "As health plans engineer their programs to bring costs to a sustainable level, every sector is encouraged to adapt to changes in how care is funded and delivered. Whenever possible, in the interest of patient care, industry leaders should seek collaboration. Transparency, consumer education and clarity on benefits and policy could improve patients' health and reduce the administrative burden across the health economy. "
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.